Nuvation Bio, Inc. (NUVB)
6.93
+0.29
(+4.37%)
USD |
NYSE |
Sep 02, 16:00
6.94
+0.01
(+0.14%)
After-Hours: 20:00
Nuvation Bio Research and Development Expense (Annual) : 115.11M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 115.11M |
| December 31, 2024 | 99.12M |
| December 31, 2023 | 71.29M |
| Date | Value |
|---|---|
| December 31, 2022 | 87.82M |
| December 31, 2021 | 69.04M |
| December 31, 2020 | 32.60M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Bristol Myers Squibb Co. | 9.492B |
| Johnson & Johnson | 14.83B |
| Pfizer Inc. | 10.25B |
| Eli Lilly & Co. | 13.34B |
| Merck & Co., Inc. | 12.51B |